Combination of HSP90 inhibitor onalespib (AT13387) with crizotinib to treat or delay resistance in NSCLC: Preclinical and Clinical Investigations. Harold Keer, Tomoko Smyth, Aurelie Courtin, Keisha Hearn, John Lyons, Nic

First Page		Document Content
Oncology Organofluorides Crizotinib Piperidines Pyrazoles Pyridines Anaplastic lymphoma kinase Hsp90 inhibitors Hsp90 Medicine Chemistry Lung cancer		Combination of HSP90 inhibitor onalespib (AT13387) with crizotinib to treat or delay resistance in NSCLC: Preclinical and Clinical Investigations. Harold Keer, Tomoko Smyth, Aurelie Courtin, Keisha Hearn, John Lyons, Nic Add to Reading List Source URL: astx.com Download Document from Source Website File Size: 948,17 KB Share Document on Facebook

	CMTF005 - Food is Medicine - Checklist_Debranded DocID: 1xVMk - View Document
	Pacemakers and Implantable Cardiac Defibrillators: Software Radio Attacks and Zero-Power Defenses Daniel Halperin† Thomas S. Heydt-Benjamin† DocID: 1xVge - View Document
	CMTF005 - Food is Medicine - Checklist_Debranded_with bleed DocID: 1xUza - View Document
	CMTF005 - Food is Medicine - Checklist_Debranded_edited DocID: 1xTtU - View Document
	PDF Document DocID: 1xSqy - View Document